title: Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis.
authors.forename: P
authors.initials: P
authors.lastname: Willeke
authors.forename: H
authors.initials: H
authors.lastname: Becker
authors.forename: B
authors.initials: B
authors.lastname: Schlüter
authors.forename: H
authors.initials: H
authors.lastname: Pavenstäd
authors.forename: E
authors.initials: E
authors.lastname: Mickholz
authors.forename: C
authors.initials: C
authors.lastname: Wierichs
authors.forename: M
authors.initials: M
authors.lastname: Gaubitz
authors.forename: H
authors.initials: H
authors.lastname: Schotte
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002097:C-Reactive Protein / Q000187:drug effects / Q000378:metabolism; D016022:Case-Control Studies; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D008263:Macrophage Migration-Inhibitory Factors / Q000097:blood* / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D000069283:Rituximab; D012720:Severity of Illness Index
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D008263:Macrophage Migration-Inhibitory Factors; D000069283:Rituximab; D002097:C-Reactive Protein; D011239:Prednisolone